期刊文献+

沙利度胺、5-氟尿嘧啶对胃癌细胞生长和凋亡作用的影响 被引量:1

Effect of thalidomide and 5-Fluorouracil on MGC-803 cell
原文传递
导出
摘要 目的探讨沙利度胺(Thai)、5-氟尿嘧啶(5-Fu)单用和联合应用对MGC-803细胞株的抑制增生、诱导凋亡的作用。方法采用AO/EB染色荧光显微镜观察处理细胞的形态变化,MTT法检测对细胞的增生抑制作用,流式细胞术(FAM)定量检测对细胞的诱导凋亡作用。结果在MTT分析中,单药Thal药物浓度≥25mg/L、5-Fu单药各浓度组与空白对照组相比均可增加对MGC-803细胞的增生抑制率(P〈0.05)。在5-Fu剂量为25mg/L时,联合用药组的增生抑制率增加更显著(P〈0.01),但两个联合用药组之间差异无统计学意义(P〉0.05);在5-Fu剂量均为12.5mg/L时,联合使用沙利度胺50mg/L或100mg/L时与5-Fu25mg/L单药组相比差异均无统计学意义(P〉0.05)。而在FAM检测中,各实验组与空白对照组相比及各实验组两两比较,凋亡率差异均有统计学意义(P〈0.01)。结论Thai和5-Fu单用时对MGC-803细胞株均有抑制增生和诱导凋亡作用,联合应用时其作用明显增强,联合使用沙利度胺时可降低5-Fu的使用剂量。 Objective To investigate the proliferation inhibition and apoptosis induction effect of thalidomide(Thai) and its joint effect with 5-Fu on MGC-803 cell line. Methods The morphological changes of MGC-803 ceils with AO/EB stain were observed under fluorescence microscope. The proliferation inhibition effect was evaluated with MTT. The apoptosis induction effect was determined by FAM. Results The results of MTT array were as below: the difference was significant between Thal groups of 25 mg/L or above concentration and the control group (P 〈0.05), 5-Fu of all testing concentrations showed significant difference compared with the control group(P 〈0.01). For combined groups with the same concentration of 25 mg/L 5-Fu, combined groups showed distinct difference from the corresponding 5-Fu group (P 〈0.01), but two combined groups showed no distinct difference with-each other (P〉0.05). For combined groups with the same concentration of 5-Fu 12.5 mg/L, 5-Fu plus 50 mg/L or 100 mg/L Thal showed no distinct difference from 5-Fu group of 25 mg/L(P 〉0.05). With FAM study, all test groups showed significant difference compared with the control group (P 〈 0.01). There was also significant difference between two test groups arbitrarily (P 〈0.01). Conclusion Both Thai and 5-Fu could inhibit the proliferation and induce the apoptosis of MGC-803 cells. The effect is reinforced with the combination significantly. Combination with Thal could decrease the concentration of 5-Fu but have the similar effect.
出处 《肿瘤研究与临床》 CAS 2009年第3期159-162,共4页 Cancer Research and Clinic
基金 济南市青年科技明星计划[济青科合字(2006)第1-13号]
关键词 胃肿瘤 沙利度胺 5-氟尿嘧啶 MGC-803细胞株 细胞凋亡 细胞增生 Stomach neoplasms Thalidomide 5-Fluorouracil MGC-803 cell line Cell apoptosis Cell proliferation
  • 相关文献

参考文献3

二级参考文献14

  • 1Zhong-LinZhang Zhi-SuLiu QuanSun.Effects of thalidomide on angiogenesis and tumor growth and metastasis of human hepatocellular carcinoma in nude mice[J].World Journal of Gastroenterology,2005,11(2):216-220. 被引量:21
  • 2Rajkumar S V, Witzig T E. A review of angiogenesis and antiangiogenie therapy with thalidomide in multiple myeloma [J].Cancer Treat Rev,2000,26:351 - 362.
  • 3Rajkumar S V, Leong T, Roche P C, et al.Prognostic value of bone marrow angiogensis in multiple myeloma[J]. Clin Cancer Rev,2000,6:3111-3116.
  • 4Singhal S, Mehta J, Eddlemon P ,et al.Marked anti-tumoreffect from anti-angiogenesis therapy with thalidomidein high risk refractory multiple myeIoma[J]. Blood,1998.98:318-322.
  • 5张之南.血液病诊断及疗效标准[M].北京:科学出版社,1997.373.
  • 6Saltz LB, Douillard JY, Pirotta N, et al. Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard. Oncologist, 2001, 6: 81-91.
  • 7Tsavaris N, Ziras N, Kosmas C, et al. Two different schedules of irinotecan (CPT-11 ) in patients with advanced colorectal carcinoma relapsing after a 5-fluoreumeil and leucovorin combination: a randomized study. Cancer Chemother Pharmaeol, 2003, 52 : 514-519.
  • 8Tournigand C, Andre T, Achille E, et al. FORFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol, 2004, 22:229-237.
  • 9Govindarajan R, Heaton KM, Broadwater R, et al. Effect of thalidomide on gastrointestinal toxic effects of irinotecan. Lancet,2000, 356 : 566-567.
  • 10黄杨卿,聂云天,王杰军.反应停的新生——抗肿瘤[J].国外医学(肿瘤学分册),2001,28(1):33-35. 被引量:13

共引文献47

同被引文献9

  • 1王天宝,董文广,李兆亭.重组人内皮抑素联合应用5氟脲嘧啶对胃癌裸鼠移植瘤的影响[J].中华普通外科杂志,2005,20(5):307-309. 被引量:7
  • 2Cutsem EV, Moiseyenko VM,Tjulandin S, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with "cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group[ J]. Clin Oncol,2007,25 ( 17 ) :2490-2491.
  • 3Woo IS, Kim KA, Jeon HM, et al. Pretreatment serum endostatin as a prognostic indicator in metastatic gastric carcinoma Int[ J]. Int J Cancer,2006,119 (12) :2901-2906.
  • 4Mererhofer C, Dunzendorfer S, Wiederrnann CJ. Theoretical basis for the activity of thalidomide[ J ]. Bio Drugs ,2001,15 (10) :681-703.
  • 5De Cicco KI, Tanaka T, Andreola F, et al. The effect of thalidomide on non-small cell lung cancer(NSCLC) cell lines:possible involvement in the PPARγ, pathway [ J ]. Carcinogenesis,2004,25 (10) : 1805-1812.
  • 6Fukumura D, Jain RK. Tumor microvasculature and microenvironment : Targets for antiangiogenesis and normalization [ J]. Microvase Res, 2007,74 ( 2 -3 ) :72 -84.
  • 7Rajkumar SV, Blood E, Vesole D,et al. Phase Ⅲ clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma:a clinical trial coordinated by the eastern cooperative oncology group [ J ]. J Clin Oncol, 2006,24 ( 3 ) : 431- 436.
  • 8Pujol JL, Breton JL, Gervais R, et al. Phase Ⅲ double-blind, placebo- controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleoO4-1FCT 00-01 [J]. J Clin Oncol,2007,25(25) :3945-3951.
  • 9张国锋,王元和,王强.沙利度胺对裸鼠原位种植人胃癌生长和转移的抑制作用[J].第二军医大学学报,2002,23(7):734-737. 被引量:5

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部